Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Document › Details

Reuters. (6/23/17). "News: BRIEF – Gensight Biologics Raises 22.5 Million Euros".

Organisations Organisation GenSight Biologics S.A. (Euronext: SIGHT)
  Organisation 2 INSTITUTIONAL INVESTOR/S
  Group OTHER
Products Product lenadogene nolparvovec (GS010)
  Product 2 investment banking
Index term Index term GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors
     


   
Record changed: 2017-06-28

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

More documents for GenSight Biologics S.A. (Euronext: SIGHT)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px




» top